leadf
logo-loader
viewCanafarma

Canafarma announces tie-up with Dutch pharma group to develop new approaches to deliver hemp-based cannabinoids

Dutch firm ApeT BV is behind the patented FLOTEX‐C system, where active ingredients are delivered in a time-released manner through a capsule that 'floats' inside the stomach

Canafarma -
Canafarma CEO David Lonsdale said he was "delighted" to be working with APeT and the initial focus will be on anti-viral, immune boosting and anti-aging formulations to boost the firm's consumer product brands

Canafarma Hemp Products Corp (CSE:CNFA) unveiled a tie-up with Dutch pharma group APeT BV to develop new approaches to deliver its hemp-based products to people.

ApeT BV is the firm behind the patented FLOTEX‐C system, where active ingredients are delivered in a time released manner via a capsule that 'floats' within the stomach.

READ: Canafarma Hemp Products says record producer who has worked with Snoop Dogg and Jason Deroulo will spearhead the firm's media efforts

The pair will develop novel hemp-based cannabinoid, drug, and nutritional supplement delivery methods through the technology.

"We are delighted to be working with APeT on something so important to the industry, and our initial focus will be on anti-viral, immune boosting and anti-aging formulations to further develop the company's consumer product brands," said David Lonsdale, CEO of Canafarma in a statement.

Many patients suffer side effects from medication or a lack of efficacy, added to which there are compliance challenges such as too many pills spread over different hours of intake per day that can lead to people skipping, or forgetting to take the right amount of medication at the right time, said the company.

"Canafarma and APeT's use of the FLOTEX‐C technology will be designed with the objective of resolving many of these problems," said Canafarma.

Canafarma Hemp Products is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market.

Shares were boosted over 6% in Toronto to C$0.51 each on the day.

---Updates for share price---

Contact the author at giles@proactiveinvestors.com

Quick facts: Canafarma

Price: 0.47 CAD

CSE:CNFA
Market: CSE
Market Cap: $88.04 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canafarma named herein, including the promotion by the Company of Canafarma in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Canafarma Hemp partners with Dutch pharma company to develop hemp-based time...

CanaFarma Hemp Products Corp. (CSE:CNFA) COO Frank Barone tells Proactive the group has partnered with Dutch pharmaceutical company APeT BV to develop hemp-based cannabinoid, drug and nutritional supplement delivery methods using its FLOTEX‐C patented technology. Barone says FLOTEX‐C ensures...

1 week, 5 days ago

2 min read